Ficlatuzumab
Showing 1 - 9 of 9
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,
Not yet recruiting
- Metastatic Head-and-neck Squamous-cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Ficlatuzumab
- +2 more
- (no location specified)
Sep 26, 2023
Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in San Francisco (Ficlatuzumab,
Terminated
- Acute Myeloid Leukemia
- +2 more
- Ficlatuzumab
- Cytarabine
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 22, 2020
NSCLC Trial in Worldwide (Ficlatuzumab, Erlotinib, )
Terminated
- Non-small Cell Lung Cancer
- Ficlatuzumab
- +2 more
-
Fresno, California
- +46 more
Oct 20, 2020
Carcinoma, Squamous Cell of Head and Neck, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head And Neck
Completed
- Carcinoma, Squamous Cell of Head and Neck
- +2 more
- Ficlatuzumab
- Cetuximab
-
Pittsburgh, Pennsylvania
- +2 more
Apr 16, 2019
Carcinoma, Squamous Cell of Head and Neck Trial in Pittsburgh (Ficlatuzumab, Cisplatin, Intensity Modulated Radiotherapy (IMRT))
Terminated
- Carcinoma, Squamous Cell of Head and Neck
- Ficlatuzumab
- +2 more
-
Pittsburgh, Pennsylvania
- +2 more
Nov 8, 2017
Carcinoma, Non-Small Cell-Lung, Lung Tumors, Lung Cancer Trial in Worldwide (AV-299 + gefitinib, Gefitinib)
Completed
- Carcinoma, Non-Small Cell-Lung
- +3 more
- AV-299 + gefitinib
- Gefitinib
-
Shatin N.T., Hong Kong
- +25 more
Apr 6, 2015
Malignant Solid Tumour, Liver Metastases Trial in Barcelona (AV-299)
Completed
- Malignant Solid Tumour
- Liver Metastases
- AV-299
-
Barcelona, SpainInvestigational Site 1
Apr 11, 2012